SARATOGA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank"gt;#AMDlt;/agt;–VisionCare, Inc. announced that the Australian Department of Health Therapeutic Goods Administra…
Category: Business
Global Amblyopia Clinical Trials Review, H2, 2018 Featuring Herantis Pharma & Santen Pharmaceutical – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Amblyopia Global Clinical Trials Review, H2, 2018″ clinical trials has been added to ResearchAndMarkets.com’s offering. Amblyopia Global Clinical Trials Review, H2, 2018” provides an overview of Amblyopia clinical trials scenario. This report provides top line data relating to the clinical trials on Amblyopia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease
Children’s Hospital Los Angeles Receives $1.6M Grant to Study Retinoblastoma
LOS ANGELES–(BUSINESS WIRE)–Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age and accounts for approximately 4% of childhood cancers. If not diagnosed early, retinoblastoma may result in loss of one or both …
BioTime to Present at Oppenheimer & Co. 29th Annual Healthcare Conference on March 20, 2019
ALAMEDA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank"gt;$BTXlt;/agt; lt;a href="https://twitter.com/hashtag/AMD?src=hash" target=&quo…
Aerpio Pharmaceuticals Announces Results From TIME-2b Study of AKB-9778 in Diabetic Retinopathy
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced top-line results from the Compa…
Acucela Signs Agreement to Develop a Compact OCT for NASA’s Deep Space Missions
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that the company signed the agreement with the Translationa…
Pivotal Trial Results for Glaukos’ iStent inject® Published in Leading Ophthalmic Journal
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
BioTime Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
ALAMEDA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank"gt;$BTXlt;/agt; lt;a href="https://twitter.com/hashtag/AMD?src=hash" target=&quo…
Compulink Previews New User Interface for its Ophthalmology SMART EHR at AGS 2019
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink previews new User Interface for its Ophthalmology SMART EHR at AGS 2019.
International Glaucoma Study Confirms Long-term Efficacy and Safety Profile of Glaukos iStent® Implantation in Combination with Cataract Surgery
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, announces a strategic shift in its U.S. commercial…
Empire Eye and Laser Center Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts
BAKERSFIELD, Calif.–(BUSINESS WIRE)–Daniel H. Chang, M.D. at Empire Eye and Laser Center in Bakersfield, Calif., is participating in the AcuFocus IC-8 clinical study for cataracts.
Clemson Eye Integrates Two Greenville Eye Care Practices into Its Network
GREENVILLE, S.C.–(BUSINESS WIRE)–This spring, Clemson Eye, Upstate’s leading provider of advanced eye care with highly trained surgeons and the latest technology, will unite with two prominent Greenville eye health practices — Montgomery & Riddle Eyecare and Donelson Eye Associates — under the Clemson Eye brand name. Combined, these practices form one of the most respected and advanced eye care systems in the nation, serving more than 100,000 patients and offering more than 10 specialties
Global Eyewear Market Trends, Share, Size, Growth, Opportunity and Forecast (2019-2024): Projected to Cross $141 Billion by 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eyewear Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering. The global eyewear market was worth US$ 120 Billion in 2018, registering a CAGR of 3.4% during 2011-2018. The market is further projected to cross US$ 141 Billion by 2024, at a CAGR of 2.6% during 2019-2024. Currently, the global demand for good-quality eyewear products is being augmented by increasing prevalen
Solutionreach Data Analysis Uncovers Optimal Patient Reminder Timing to Maximize Appointments
LEHI, Utah–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AppointmentReminder?src=hash" target="_blank"gt;#AppointmentReminderlt;/agt;–Solutionreach, the leader in patient relationship management (PRM) solutions, today re…
Second Sight to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 Conference Call
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, will release it…
Ophthotech to Present at the Cowen and Company 39th Annual Health Care Conference
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that Kourous A. Rezaei, M.D., CMO, will present an overview of the Company at the Cowen and Company Health Care Conference
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in March
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delive…
Roberto Conte Promoted to Vice President, Operations – East
DALLAS–(BUSINESS WIRE)–Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the promotion of Roberto Conte to Vice President, Operations – East, effective March 1. Mr. Conte will oversee operations in …
Aaron Cho Joins Eyecare Services Partners as Chief Financial Officer
DALLAS–(BUSINESS WIRE)–Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the appointment of Aaron Cho as Chief Financial Officer, effective March 4. Mr. Cho was previously CFO of Access Dental, a successf…